Differential Air Pressure Technology for Treatment of Diabetic Elderly

Status Completed

Clinical Trial Summary

Aging can be defined as sequential deterioration that occurs in elderly people including weakness, loss of mobility, decline of physical capabilities, increase susceptibility to disease and many other age-related physiological changes .The beginning of old age in most developed countries is about 60 or 65 years old. Diabetes mellitus (DM) and most commonly type 2 DM is one of the most common chronic non-communicable diseases affecting old people in Saudi Arabia which might be resulted from decline in physical activities. Polyneuropathy (PN) and its serious consequences represent the most common complication in diabetic mellitus which could contribute to an increased gait abnormality and risk of falling.

Clinical Trial Description

Disability and reduction of quality of life are the largest costs of diabetes and its complications. So taking active intervention to reduce the risk of falls, improve gait performance and improve the quality of life in elderly with DPN is very important. Lower extremity aerobic exercise training via treadmill aiming for improving patients' physical activity levels is an important part in the rehabilitation program to enhance balance and walking functions and reducing the fall risk, .Treadmill training using s low-load walking provided by an emerging technology called lower body positive pressure (LBPP) that effectively reduces body weight could be preferable than other methods of unweighting treadmill because the air pressure is applied uniformly over the lower body. This kind of anti-gravity treadmill is ideal in reducing the formation of pain and pressure points that are common with harness-based unweighting systems. Many other advantages are also associated with this unique type of antigravity technology that could give it the superiority than the other types of unweighting treadmills in enhancing walking performance, reducing the risk of fall and improving quality of life in Saudi elderly people with DPN. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04620265
Study type	Interventional
Source	Umm Al-Qura University
Contact
Status	Completed
Phase	N/A
Start date	March 1, 2020
Completion date	October 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06040567` - Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
Completed	`NCT02423434` - Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes
Completed	`NCT05542901` - Comparison of Joint Position Sense in Diabetic and Traumatic Transtibial Amputees	N/A
Withdrawn	`NCT01536236` - Spinal Cord Stimulation for Diabetic Polyneuropathy	N/A
Active, not recruiting	`NCT01175928` - Pneumatic Medicine: A Transformative Treatment for Diabetic Peripheral Neuropathy	Phase 1/Phase 2
Completed	`NCT00993070` - Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic Neuropathy	Phase 2/Phase 3
Completed	`NCT00539175` - Treatment of Painful Diabetic Neuropathy With Photon Stimulation	N/A
Completed	`NCT00278980` - Effect of C-Peptide on Diabetic Peripheral Neuropathy	Phase 2
Completed	`NCT04593992` - HTEMS Treatment of Diabetic Polyneuropathy	N/A
Completed	`NCT01465620` - Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study	Phase 3
Completed	`NCT01079325` - Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy	Phase 2
Completed	`NCT00406458` - Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy	Phase 2
Recruiting	`NCT06071975` - Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy	Phase 3
Recruiting	`NCT06072573` - Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy	Phase 3
Recruiting	`NCT05521737` - Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy	N/A
Completed	`NCT01847937` - Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy	N/A
Completed	`NCT00476931` - Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy	Phase 2
Completed	`NCT00977483` - Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)	Phase 3
Completed	`NCT01006915` - Surgical Decompression for Diabetic Neuropathy in the Foot	N/A
Completed	`NCT00501202` - Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Differential Air Pressure Technology for Treatment of Diabetic Elderly Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms